Evidence map›Paper›PMID 40312305›Full record

ArticleBMC gastroenterology2025

Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017-2020.

Yigui Zou, Yu Dai, Ziyuan Li, Baixian Lin, Hu Chen, Zeling Zhuang, Wenwen Li, Qinghua Yang, Dongling Dai

Abstract read
In one paragraph

Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yigui ZouKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Yu DaiChildren's Healthcare and Mental Health Center, Shenzhen Children's Hospital, Shenzhen , Guangdong, 518036, China.
Ziyuan LiKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Baixian LinKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Hu ChenKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Zeling ZhuangKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Wenwen LiKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Qinghua YangKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China.
Dongling DaiKey Laboratory for Precision Diagnosis and Treatment of Pediatric Digestive System Disease, Endoscopy Center, Shenzhen Children's Hospital, Shenzhen, Guangdong, 518036, China. daidong3529@sina.com.

Funding

Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children's Hospital LCYJ2022059Shenzhen Science and Technology Innovation Program JCYJ20220818102801004
6 · The paper itself

Abstract

backgroundMetabolic dysfunction-associated fatty liver disease (MAFLD) has become the most prevalent chronic liver condition in adolescents. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has shown promise in adult MAFLD detection but requires pediatric-specific validation, particularly when combined with anthropometric measures. This study investigated the association between modified TyG indices and MAFLD, and evaluated their predictive value in adolescents.

methodsThis cross-sectional study analyzed data from 532 adolescents (12-18 years) in the 2017-2020 National Health and Nutrition Examination Survey (NHANES) with complete records. MAFLD diagnosis was based on transient elastography plus metabolic criteria. The investigators employed multivariate linear regression and restricted cubic splines (RCS) to examine linear and nonlinear relationships between modified TyG indices and CAP values. Subgroup analyses were stratified by obesity status, and sensitivity analyses were performed on the NAFLD cohort (n = 527). Receiver operating characteristic (ROC) curve analysis, using Youden's index, evaluated the predictive performance of TyG indices for MAFLD identification.

resultsAmong 130 MAFLD adolescents (vs 402 controls), modified TyG indices demonstrated significantly stronger associations with CAP in fully adjusted models compared to the original TyG index. TyG-WC showed the highest diagnostic accuracy (AUC = 0.923, 95%CI:0.900-0.947), followed by TyG-BMI (AUC = 0.917) and TyG-WHtR (AUC = 0.915), while the original TyG index performed poorly (AUC = 0.673). Subgroup analyses revealed particularly strong associations in non-obese participants, and sensitivity analyses confirmed result robustness after excluding potential confounders. Optimal cutoff values provided clinically useful screening thresholds, with TyG-WC achieving 94% sensitivity at 665.94.

conclusionThis study demonstrates that modified TyG indices incorporating anthropometric parameters (particularly TyG-WC) significantly outperform the original TyG index for MAFLD detection in adolescents, with superior diagnostic accuracy (AUC 0.915-0.923). The robust predictive performance maintained in sensitivity analyses and non-obese subgroups supports their clinical utility as simple, non-invasive screening tools for pediatric MAFLD risk stratification.

Indexed as

Blood GlucoseNon-alcoholic Fatty Liver DiseaseTriglyceridesAdolescentBiomarkersChildCross-Sectional StudiesElasticity Imaging TechniquesFemaleHumansInsulin ResistanceMaleNutrition SurveysPredictive Value of TestsROC CurveUnited StatesBiomarkersBlood GlucoseTriglyceridesAdolescentInsulin resistanceMetabolic dysfunction-associated fatty liver diseaseNHANESTyG index

Identifiers

PMID40312305
PMCPMC12044992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.